Efficacy and tolerability of voriconazole in the treatment of pulmonary aspergillosis

H. Aoki, T. Hisada, T. Ishizuka, N. Sunaga, Y. Shimizu, M. Utsugi, K. Kaira, N. Yanagitani, T. Aomori, K. Yamamoto, Y. Tokue, K. Dobashi, M. Mori (Maebashi, Japan)

Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Session: Antibiotic treatment in community-acquired pneumonia
Session type: Electronic Poster Discussion
Number: 1873
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Aoki, T. Hisada, T. Ishizuka, N. Sunaga, Y. Shimizu, M. Utsugi, K. Kaira, N. Yanagitani, T. Aomori, K. Yamamoto, Y. Tokue, K. Dobashi, M. Mori (Maebashi, Japan). Efficacy and tolerability of voriconazole in the treatment of pulmonary aspergillosis. Eur Respir J 2007; 30: Suppl. 51, 1873

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical efficacy and safety of micafungin in patients with pulmonary aspergillosis
Source: Eur Respir J 2006; 28: Suppl. 50, 788s
Year: 2006

Pulmonary aspergillosis during pregnancy: tolerability and safety of terbinafine
Source: Eur Respir J 2002; 20: Suppl. 38, 352s
Year: 2002

Treatment of chronic pulmonary aspergillosis by voriconazole compared with micafungin
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009


Effectiveness of itraconazole and systemic steroids in the treatment of ABPA
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018


A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma
Source: Eur Respir J, 52 (3) 1801159; 10.1183/13993003.01159-2018
Year: 2018



Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis
Source: Eur Respir J 2012; 40: 271-273
Year: 2012


Efficacy of nebulised liposomal amphotericin B in the attack and maintenance treatment of ABPA
Source: Eur Respir J 2012; 39: 1261-1263
Year: 2012


Efficacy and safety of Linezolid in pneumonias
Source: Eur Respir J 2002; 20: Suppl. 38, 420s
Year: 2002

Retrospective study on the combined use of voriconazole and prednisolone in the treatment of acute allergic bronchopulmonary aspergillosis (ABPA).
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019

Evaluation of the efficacy and safety of moxifloxacin in the treatment of drug-resistant pulmonary tuberculosis; a clinical trial
Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis
Year: 2008



Evaluation of the efficacy and safety of levofloxacin in the treatment of resistant pulmonary tuberculosis; a clinical trial
Source: Eur Respir J 2002; 20: Suppl. 38, 546s
Year: 2002

The efficacy, safety and feasibility of inhaled amikacin for the treatment of refractory non-tuberculous mycobacterial lung diseases
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017

Treatment of chronic necrotizing pulmonary aspergillosis (CNPA) with micafungin (MCFG)
Source: Eur Respir J 2005; 26: Suppl. 49, 410s
Year: 2005

Caspofungin to treat invasive pulmonary aspergillosis in sarcoidosis
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012


Clinical efficacy of oral sildenafil therapy in the treatment of pulmonary hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 347s
Year: 2007

Efficacy of oral add-on therapy in patients with pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009

Efficacy and safety of moxifloxacin in the outpatient treatment of exacerbations of chronic obstructive pulmonary disease
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018


Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide
Source: Eur Respir J 2002; 20: 127-133
Year: 2002



Efficacy and safety of combined use of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Year: 2021


Efficacy and safety of meropenem–clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB
Source: Eur Respir J 2013; 41: 1386-1392
Year: 2013